Hours

Mon – Fri
9:00 am – 5:00 pm
Saturday
9:00 am – 4:00 pm

Dysport

What Is Dysport?

Dysport (abobotulinumtoxinA) is an injectable medicine made from botulinum toxin type A that temporarily relaxes the muscles it is injected into. In cosmetic care, the FDA has approved it to temporarily improve moderate to severe frown lines between the eyebrows (glabellar lines) in adults younger than 65.

Dysport was first approved in the US in 2009. It is also approved to treat cervical dystonia (involuntary tightening of the neck muscles) in adults and muscle stiffness (spasticity) in patients 2 years and older. One brand of botulinum toxin can't be substituted for another.

Dysport at a Glance

Cosmetic use (FDA-approved) Moderate to severe frown lines between the eyebrows in adults under 65
How it works Blocks the nerve signals that make targeted muscles contract
How it's given Injected into the muscle by a clinician
When results appear Median of 2 to 4 days in clinical trials, sometimes within 24 hours
How long it lasts Up to 4 months per the FDA label; up to 5 to 6 months in some studies
Downtime Most people return to everyday activities right away
Common side effects Injection-site pain or reaction, headache, eyelid swelling, drooping eyelid
FDA status Approved in 2009; carries a boxed warning about spread of toxin effect

What Is Dysport Used For?

Dysport's only FDA-approved cosmetic use is softening the vertical frown lines between the brows, which form when the corrugator and procerus muscles contract. Expert panels have also issued guidance on using abobotulinumtoxinA in other facial areas. International consensus recommendations for a ready-to-use form sold in Europe cover crow's feet, forehead lines, bunny lines, a dimpled chin and neck bands, but these uses are not on the US label.

How Does Dysport Work?

Dysport works by blocking the nerve signals that make targeted muscles tighten; its label classifies it as an acetylcholine release inhibitor. When the muscles between the brows relax, the lines over them soften. Botulinum toxin treatment does not affect your ability to feel. The effect is temporary, so treatment is repeated to maintain results.

What to Expect From Dysport Treatment

A Dysport treatment can be done in a single office visit, and most people return to everyday activities right away.

Before

Tell your provider about all medicines, including blood thinners and aspirin, plus herbs and supplements. Also mention past eye or face surgery and pregnancy or plans to become pregnant.

During

For frown lines, the label calls for 50 units given as five injections of 10 units: two in each corrugator muscle and one in the procerus muscle.

After

  • Don't rub or massage the treated areas, and apply makeup gently.
  • Wait two hours before strenuous activity, such as working out or heavy lifting.
  • Repeat treatments should be given no more often than every 3 months.

Results

In a study of 158 adults with moderate to severe frown lines, 89.5% of those given Dysport had no or mild frown lines at day 30 by investigator assessment, compared with 7.5% given placebo.

Dysport Side Effects

Side effects of botulinum toxin treatments such as Dysport tend to be mild and temporary. In frown-line trials, the most common (2% or more) were colds (nasopharyngitis), upper respiratory infection, headache, injection-site pain or reaction, eyelid swelling, drooping eyelid, sinusitis, nausea and blood in the urine. Call your clinician right away if you notice vision changes, eye dryness, hives, dizziness, or trouble swallowing, speaking or breathing.

Dysport Warnings

Dysport's FDA label includes these key warnings:

  • Boxed warning: the effect of any botulinum toxin may spread beyond the injection site and cause botulism-like symptoms hours to weeks later. Swallowing and breathing problems can be life-threatening.
  • Units aren't interchangeable: Dysport units can't be compared with or converted into units of other botulinum toxin products.
  • Dry eye: may occur after frown-line treatment.

Who Shouldn't Get Dysport?

You should not receive Dysport if you are allergic to any botulinum toxin product or its ingredients, are allergic to cow's milk protein, or have an infection at the planned injection site. Tell your provider if you have a nerve or muscle condition such as ALS, myasthenia gravis or Lambert-Eaton syndrome, or a history of swallowing or breathing problems.

Dysport vs. Botox

Dysport and Botox Cosmetic are both botulinum toxin type A products, but their doses and approved cosmetic uses differ.

Dysport Botox Cosmetic
Generic name AbobotulinumtoxinA OnabotulinumtoxinA
FDA-approved cosmetic uses Frown lines (adults under 65) Frown lines, crow's feet, forehead lines and neck (platysma) bands
Labeled frown-line dose 50 units 20 units
Labeled duration for frown lines Up to 4 months About 3 to 4 months
Cow's milk protein allergy Listed as a contraindication Not listed

Because units can't be compared, a higher Dysport number doesn't mean a stronger treatment. A network meta-analysis of frown-line trials found no significant differences in treatment-related side effect rates among botulinum toxin type A products, including Dysport and Botox.

Dysport at GENEVA

At GENEVA Primary Care & Med Spa in Alpharetta, GA, a provider evaluates whether Dysport suits your frown lines or other concern and reviews your health history and medicines. Based on that evaluation, your provider recommends treatment at GENEVA or a referral to a specialist.

Learn more on our Dysport treatment and Botox pages. GENEVA serves patients from Alpharetta, Johns Creek, Milton, Roswell and Cumming.

Related Terms

Dysport FAQs

Is Dysport safe?

Dysport is FDA-approved for frown lines, and side effects of botulinum toxin treatment tend to be mild and temporary. In frown-line trials, common side effects included headache, injection-site pain, eyelid swelling and drooping eyelid. Dysport carries a boxed warning that the effects of Dysport and all botulinum toxin products can spread and cause swallowing or breathing problems hours to weeks later. The American Academy of Dermatology warns against toxin bought online or injected at a salon, party or someone's home. Get care right away for any trouble swallowing, speaking or breathing.

How long does Dysport last?

Dysport for frown lines may last up to four months, according to its FDA label, and some studies report longer results. A 2024 review found that pivotal trials showed effects lasting up to 5 months, and newer studies up to 6 months. Repeat treatments should be given no more often than every 3 months. The American Academy of Dermatology notes that with repeated treatment the muscle may thin, which can lead to longer-lasting results.

How long does Dysport take to work?

Dysport typically starts working in 2 to 4 days, and some people see a change within 24 hours. In an analysis of phase 3 frown-line trials, median onset was 3 days, and 19.7% of participants noticed an effect by day 1. A later trial reported a median onset of 2 days, with 34% noticing results on day 1. Men responded less often in fixed-dose studies than in a study that adjusted the dose for muscle mass, so talk with your provider if results seem weak.

What is the difference between Dysport and Botox?

Dysport and Botox Cosmetic are both botulinum toxin type A injections that relax muscles, but they are different products with different doses and approved uses. Dysport is FDA-approved for frown lines in adults under 65, while Botox Cosmetic is approved for frown lines, crow's feet, forehead lines and neck bands. The labeled frown-line dose is 50 units of Dysport versus 20 units of Botox Cosmetic. In a trial of 520 Chinese adults, Dysport worked about as well as Botox (non-inferior) for frown lines.

How many units of Dysport equal one unit of Botox?

No exact conversion exists, because the FDA labels state that units of each botulinum toxin product can't be compared with or converted into units of another. Researchers have still studied rough ratios. A systematic review of movement-disorder trials found that roughly 2.5 to 3 units of Dysport for each unit of Botox gave comparable safety and effectiveness. That research looked at medical uses, not cosmetic ones. Your provider doses each product on its own scale, so a bigger Dysport number does not mean a stronger treatment.

What should I avoid after Dysport?

After Dysport, avoid rubbing or massaging the treated areas and wait two hours before strenuous exercise, so the toxin doesn't spread to muscles you didn't want treated. The American Academy of Dermatology says most people return to everyday activities right away and can apply makeup immediately, as long as they don't press or rub it in. Any bruising usually lasts about a week. If you develop blurred vision, drooping eyelids or muscle weakness, don't drive or operate machinery, and call your clinician.

Can a primary care provider evaluate me for Dysport?

Yes. A primary care provider can review your health history, medicines and allergies to see whether Dysport is a reasonable option for you. At GENEVA in Alpharetta, a provider evaluates your concern and then recommends either treatment at GENEVA or a referral to a specialist. Mention any nerve or muscle disorder, swallowing or breathing problems, cow's milk protein allergy, past face or eye surgery, or pregnancy. Dysport may not work well on drooping eyelids, excess eyelid skin, or deeply scarred, thick or oily skin.

References

GENEVA's glossary is based on evidence-backed information from government health agencies, medical societies and peer-reviewed research.

View sources
  1. American Academy of Dermatology Association. Botulinum toxin therapy: Overview (https://www.aad.org/public/cosmetic/wrinkles/botulinum-toxin-overview). Accessed 10/30/2026.
  2. American Academy of Dermatology Association. Botulinum toxin therapy: FAQs (https://www.aad.org/public/cosmetic/wrinkles/botulinum-toxin-faqs). Accessed 10/30/2026.
  3. American Academy of Dermatology Association. Botulinum toxin therapy: Preparation (https://www.aad.org/public/cosmetic/wrinkles/botulinum-toxin-preparation). Accessed 10/30/2026.
  4. Ipsen Biopharmaceuticals, Inc.; DailyMed, National Library of Medicine. DYSPORT- botulinum toxin type a injection, powder, lyophilized, for solution (https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=97513722-8426-4ce3-b85d-0e08e436a140&type=display). Last updated 9/2023. Accessed 10/30/2026.
  5. MedlinePlus, National Library of Medicine. AbobotulinumtoxinA Injection: MedlinePlus Drug Information (https://medlineplus.gov/druginfo/meds/a609035.html). Last updated 9/15/2023. Accessed 10/30/2026.
  6. Allergan, Inc.; DailyMed, National Library of Medicine. BOTOX COSMETIC- onabotulinumtoxina injection, powder, lyophilized, for solution (https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=485d9b71-6881-42c5-a620-a4360c7192ab&type=display). Last updated 10/2024. Accessed 10/30/2026.
  7. Kane M, Donofrio L, Ascher B, et al. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations (https://pubmed.ncbi.nlm.nih.gov/20919448/). J Drugs Dermatol. 2010 Jan;9(1 Suppl):s7-22; quiz s23-5. Accessed 10/30/2026.
  8. Brandt F, Swanson N, Baumann L, et al. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety (https://pubmed.ncbi.nlm.nih.gov/19549186/). Dermatol Surg. 2009 Dec;35(12):1893-901. Accessed 10/30/2026.
  9. Schlessinger J, Monheit G, Kane MA, et al. Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A (https://pubmed.ncbi.nlm.nih.gov/21745254/). Dermatol Surg. 2011 Oct;37(10):1434-42. Accessed 10/30/2026.
  10. Schlessinger J, Friedmann DP, Mayoral F, et al. AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data (https://pubmed.ncbi.nlm.nih.gov/34491022/). J Drugs Dermatol. 2021 Sep 1;20(9):988-995. Accessed 10/30/2026.
  11. Cohen JL, Cox SE, Glaser DA, et al. A Review of Current Data on Duration of Effect in Glabellar Lines After Treatment With AbobotulinumtoxinA 50 U (https://pubmed.ncbi.nlm.nih.gov/39196827/). Dermatol Surg. 2024 Sep 1;50(9S):S5-S11. Accessed 10/30/2026.
  12. Dashtipour K, Chen JJ, Espay AJ, et al. OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review (https://pmc.ncbi.nlm.nih.gov/articles/PMC4836618/). Mov Disord Clin Pract. 2016 Mar-Apr;3(2):109-115. Accessed 10/30/2026.
  13. Li X, Sui C, Xia X, et al. Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials (https://pubmed.ncbi.nlm.nih.gov/36097079/). Aesthetic Plast Surg. 2023 Feb;47(1):365-377. Accessed 10/30/2026.
  14. Wu Y, Fang F, Lai W, et al. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study (https://pmc.ncbi.nlm.nih.gov/articles/PMC9944721/). Aesthetic Plast Surg. 2023;47(1):351-364. Accessed 10/30/2026.
  15. Ascher B, Rzany BJ, Kestemont P, et al. International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10790960/). Aesthet Surg J. 2024 Feb;44(2):192-202. Accessed 10/30/2026.